logo-loader

Milestone Scientific reveals study that shows the cost-effectiveness of its CompuFlo Epidural System

Published: 17:49 20 Apr 2020 BST

Milestone Scientific Inc (NYSEAMERICAN:MLSS) CEO Len Osser tells Proactive a study was presented at the American Society of Regional Anesthesia and Pain Medicine that validates the cost benefits of Milestone's CompuFlo Epidural System.

What's more, Osser says, is the company recently raised $5M gross to give it more than a one year's runway in the event the coronavirus continues to be widespread. Osser also says a large hospital recently contacted the company, as it was interested to begin trialing its cath check product this week to limit multiple contact between doctors and post-partum patients.

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

1 hour, 24 minutes ago